Inventor · disambiguated record
M. Zouhair Atassi
Also filed as: ATASSI M ZOUHAIR
16 granted patents·6 pending applications·184 citations·filing 1994–2011
93Inventor score
Files withALLERGAN INC10ATASSI M ZOUHAIR6ALLERGAN INC AND BAYLOR COLLEG1NASA1REGENTS BAYLOR COLLEGE OF MEDICINE1
Top patents by PatentIndex Score
22 records- 0193US7341843B2Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapyALLERGAN INC·Filed 2004·Granted Mar 11, 2008·48 cites·75 claims
- 0291US7691587B2Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptidesALLERGAN INC·Filed 2007·Granted Apr 6, 2010·8 cites·21 claims
- 0390US7670788B2Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptidesALLERGAN INC·Filed 2008·Granted Mar 2, 2010·6 cites·17 claims
- 0490US7531179B2BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapyALLERGAN INC·Filed 2007·Granted May 12, 2009·11 cites·11 claims
- 0590US7462699B2BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapyALLERGAN INC·Filed 2007·Granted Dec 9, 2008·11 cites·19 claims
- 0689US7855268B2Tolerogizing compositions comprising botulinum toxin type B peptidesALLERGAN INC·Filed 2007·Granted Dec 21, 2010·5 cites·6 claims
- 0785US7635484B2BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapyALLERGAN INC·Filed 2007·Granted Dec 22, 2009·5 cites·10 claims
- 0879US8236513B2Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin A peptidesATASSI M ZOUHAIR·Filed 2008·Granted Aug 7, 2012·3 cites·12 claims
- 0978US7972801B2Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptidesALLERGAN INC·Filed 2010·Granted Jul 5, 2011·1 cites·9 claims
- 1077US7968304B2Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptidesALLERGAN INC·Filed 2010·Granted Jun 28, 2011·1 cites·16 claims
- 1177US6048529APVA or PEG conjugates of peptides for epitope-specific immunosuppressionFiled 1995·Granted Apr 11, 2000·46 cites·21 claims
- 1273US8137675B2Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapyATASSI M ZOUHAIR·Filed 2009·Granted Mar 20, 2012·1 cites·19 claims
- 1372US5578496ADetection of autoantibodies associated with the disease myasthenia gravisREGENTS BAYLOR COLLEGE OF MEDICINE·Filed 1994·Granted Nov 26, 1996·36 cites·11 claims
- 1467US2010284958A1BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin TherapyATASSI M ZOUHAIR·Filed 2009·Application pending·0 cites
- 1555US2008171347A1Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptidesATASSI M ZOUHAIR·Filed 2008·Application pending·0 cites
- 1651US2010111962A1Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B PeptidesALLERGAN INC AND BAYLOR COLLEG·Filed 2010·Application pending·0 cites
- 1749US2007258992A1Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a PeptidesATASSI M ZOUHAIR·Filed 2005·Application pending·0 cites
- 1848US7541159B2Molecular-specific urokinase antibodiesNASA·Filed 2004·Granted Jun 2, 2009·0 cites·12 claims
- 1944US2008274480A1Botulinum Toxin Type a Immunoresistant AssayALLERGAN INC·Filed 2005·Application pending·0 cites
- 2044US2013330369A1Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants ThereofATASSI M ZOUHAIR·Filed 2011·Application pending·0 cites
- 2133US5759834ASynthetic sterically-constrained pepzyme catalysts modeled on lysozyme and ribonucleaseFiled 1995·Granted Jun 2, 1998·1 cites·4 claims
- 2231US5861477ACyclic peptide catalysts modeled on enzyme active sitesFiled 1994·Granted Jan 19, 1999·1 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when M. Zouhair Atassi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →